Chan, L.K.Y.; Lau, T.S.; Chung, K.Y.; Tam, C.; Cheung, T.H.; Yim, S.F.; Lee, J.H.S.; Leung, R.W.T.; Qin, J.; Or, Y.Y.Y.;
et al. Short-Form Thymic Stromal Lymphopoietin (sfTSLP) Is the Predominant Isoform Expressed by Gynaecologic Cancers and Promotes Tumour Growth. Cancers 2021, 13, 980.
https://doi.org/10.3390/cancers13050980
AMA Style
Chan LKY, Lau TS, Chung KY, Tam C, Cheung TH, Yim SF, Lee JHS, Leung RWT, Qin J, Or YYY,
et al. Short-Form Thymic Stromal Lymphopoietin (sfTSLP) Is the Predominant Isoform Expressed by Gynaecologic Cancers and Promotes Tumour Growth. Cancers. 2021; 13(5):980.
https://doi.org/10.3390/cancers13050980
Chicago/Turabian Style
Chan, Loucia Kit Ying, Tat San Lau, Kit Ying Chung, Chit Tam, Tak Hong Cheung, So Fan Yim, Jacqueline Ho Sze Lee, Ricky Wai Tak Leung, Jing Qin, Yvonne Yan Yan Or,
and et al. 2021. "Short-Form Thymic Stromal Lymphopoietin (sfTSLP) Is the Predominant Isoform Expressed by Gynaecologic Cancers and Promotes Tumour Growth" Cancers 13, no. 5: 980.
https://doi.org/10.3390/cancers13050980
APA Style
Chan, L. K. Y., Lau, T. S., Chung, K. Y., Tam, C., Cheung, T. H., Yim, S. F., Lee, J. H. S., Leung, R. W. T., Qin, J., Or, Y. Y. Y., Lo, K. W., & Kwong, J.
(2021). Short-Form Thymic Stromal Lymphopoietin (sfTSLP) Is the Predominant Isoform Expressed by Gynaecologic Cancers and Promotes Tumour Growth. Cancers, 13(5), 980.
https://doi.org/10.3390/cancers13050980